NCT04790448View on ClinicalTrials.gov

Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Colorectal Cancer Metastatic
Interventions
DRUG

Cetuximab

Route of administration: Intravenous

DRUG

Irinotecan

Route of administration: Intravenous

DRUG

Vemurafenib

Route of administration: Oral

Trial Locations (1)

510060

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT04790448 - Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter